Your browser doesn't support javascript.
loading
STAT3/p53 pathway activation disrupts IFN-ß-induced dormancy in tumor-repopulating cells.
Liu, Yuying; Lv, Jiadi; Liu, Jinyan; Liang, Xiaoyu; Jin, Xun; Xie, Jing; Zhang, Le; Chen, Degao; Fiskesund, Roland; Tang, Ke; Ma, Jingwei; Zhang, Huafeng; Dong, Wenqian; Mo, Siqi; Zhang, Tianzhen; Cheng, Feiran; Zhou, Yabo; Jia, Qingzhu; Zhu, Bo; Kong, Yan; Guo, Jun; Zhang, Haizeng; Hu, Zhuo-Wei; Cao, Xuetao; Qin, F Xiao-Feng; Huang, Bo.
Affiliation
  • Liu Y; National Key Laboratory of Medical Molecular Biology and Department of Immunology, Institute of Basic Medical Sciences, and.
  • Lv J; Clinical Immunology Center, Chinese Academy of Medical Sciences, Beijing, China.
  • Liu J; National Key Laboratory of Medical Molecular Biology and Department of Immunology, Institute of Basic Medical Sciences, and.
  • Liang X; National Key Laboratory of Medical Molecular Biology and Department of Immunology, Institute of Basic Medical Sciences, and.
  • Jin X; National Key Laboratory of Medical Molecular Biology and Department of Immunology, Institute of Basic Medical Sciences, and.
  • Xie J; National Key Laboratory of Medical Molecular Biology and Department of Immunology, Institute of Basic Medical Sciences, and.
  • Zhang L; National Key Laboratory of Medical Molecular Biology and Department of Immunology, Institute of Basic Medical Sciences, and.
  • Chen D; National Key Laboratory of Medical Molecular Biology and Department of Immunology, Institute of Basic Medical Sciences, and.
  • Fiskesund R; National Key Laboratory of Medical Molecular Biology and Department of Immunology, Institute of Basic Medical Sciences, and.
  • Tang K; National Key Laboratory of Medical Molecular Biology and Department of Immunology, Institute of Basic Medical Sciences, and.
  • Ma J; Science for Life Laboratory, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.
  • Zhang H; Department of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Stockholm, Sweden.
  • Dong W; Department of Biochemistry and Molecular Biology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Mo S; Department of Biochemistry and Molecular Biology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Zhang T; Department of Biochemistry and Molecular Biology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Cheng F; National Key Laboratory of Medical Molecular Biology and Department of Immunology, Institute of Basic Medical Sciences, and.
  • Zhou Y; National Key Laboratory of Medical Molecular Biology and Department of Immunology, Institute of Basic Medical Sciences, and.
  • Jia Q; National Key Laboratory of Medical Molecular Biology and Department of Immunology, Institute of Basic Medical Sciences, and.
  • Zhu B; National Key Laboratory of Medical Molecular Biology and Department of Immunology, Institute of Basic Medical Sciences, and.
  • Kong Y; National Key Laboratory of Medical Molecular Biology and Department of Immunology, Institute of Basic Medical Sciences, and.
  • Guo J; Institute of Cancer, Xinqiao Hospital, Third Military Medical University, Chongqing, China.
  • Zhang H; Institute of Cancer, Xinqiao Hospital, Third Military Medical University, Chongqing, China.
  • Hu ZW; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Institute, Beijing, China.
  • Cao X; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Institute, Beijing, China.
  • Qin FX; Department of Colorectal Surgery, National Cancer Center/Cancer Hospital, and.
  • Huang B; Molecular Immunology and Pharmacology Group, State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
J Clin Invest ; 128(3): 1057-1073, 2018 03 01.
Article in En | MEDLINE | ID: mdl-29431732
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplastic Stem Cells / Tumor Suppressor Protein p53 / Interferon-beta / STAT3 Transcription Factor Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: J Clin Invest Year: 2018 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplastic Stem Cells / Tumor Suppressor Protein p53 / Interferon-beta / STAT3 Transcription Factor Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: J Clin Invest Year: 2018 Document type: Article